4.5 Article

Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6β-naltrexol in guinea pig plasma

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2004.08.016

Keywords

naltrexone; 6 beta-naltrexol; pharmacokinetics

Funding

  1. NIDA NIH HHS [R01DA13425] Funding Source: Medline

Ask authors/readers for more resources

A quantitative liquid chromatographic-electrospray ionization mass spectrometry method for the determination of naltrexone and 6beta-naltrexol in guinea pig plasma has been developed and validated using naloxone as an internal standard. A single step precipitation-extraction technique was carried out to extract the plasma samples using acetonitrile: ethyl acetate (1:1, v/v). The chromatographic separation was performed on a C-18 column using a mobile phase consisting of 35:65 (v/v) acetonitrile:2 mM ammonium acetate with 0.01 mM ammonium citrate at a flow rate of 0.25 mL/min. The analyte was detected after positive electrospray ionization using selected ion monitoring (SIM) mode. The mean recoveries for naltrexone, naltrexol, and naloxone were 91.7, 89.3, and 99.0%, respectively. The lower limit of quantification (LLOQ) for naltrexone and 6beta-naltrexol was 1.25 ng/mL, and the limit of detection (LOD) was 0.75 ng/mL. The method was applied to a pharmacokinetic study in order to assess the drug disposition of naltrexone in guinea pigs. (C) 2004 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available